Browse > Article

A Stereoselective Asymmetric Synthesis of Antibiotic (-)-Fumagillol Using Claisen Rearrangement and Intramolecular Ester Enolate Alkylation as Key Steps  

Kim Deukjoon (College of Pharmacy, Seoul National University)
Ahn Soon Kil (New Drug Research Laboratories, Chong Kun Dang Research Institute Cheonan)
Bae Hoon (Department of Chemistry and Biochemistry, Florida State University)
Kim Hak Sung (Wonkwang University, College of Pharmacy)
Publication Information
Archives of Pharmacal Research / v.28, no.2, 2005 , pp. 129-141 More about this Journal
Abstract
(-)-Fumagillol (1), a hydrolysis product of fumagillin, has been synthesized by several group from commercially available 1,2:5,6-di-O-isopropylidene-${\alpha}$-D-allofuranose in a highly stereoselective manner. Chiral centers on C5 and C6 came from D-allofuranose and the asymmetric center on C4 was accomplished by 1,3-chirality transfer using the Claisen rearrangement on a chiral allyl alcohol. Chirality, which is necessary on an epoxide consisting of the spiro-ring system, was diastereoselectively constructed by the well-known reaction, intramolecular ester enolate alkylation (IEEA), which showed that this reaction can be applied to the alpha-alkoxy ester system. The epoxide on the side chain was regioselectively introduced by the difference between the number of substituents on the vinyl groups. This accomplishment proved that IEEA can be a useful tool for the synthesis of complex molecules.
Keywords
Fumagillol; Fumagillin; Total synthesis; Stereoselective; 1,3-Chirality transfer;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Hutchings, M., Moffat, D., and Simpkins, N. S., A concise synthesis of fumagillol. Synlett., 5, 661-663. (2001)
2 Iversen, T. and Bundle, D. R., Benzyl trichloroacetimidate, a versatile reagent for acid-catalyzed benzylation of hydroxygroups. J. Chem. Soc., Chem. Commun., 23, 1240-1243, (1981)   DOI
3 Killough, J. J., Magill, G. B., and Smith, R. C. The treatment of amebiasis with fumagillin. Science, 115, 71-72 (1952)   DOI   PUBMED
4 Kim, D., Ahn, S. K., Bae, H., Choi, W. J., and Kim, H. S., An asymmetric total synthesis of (-)-fumagillol. Tetrahedron Lett., 38(25), 4437-4440 (1997)   DOI   ScienceOn
5 McCowen M. C., Callender, M. E., and Lawlis, J. F. Jr., Fumagillin (H-3), a new antibiotic with amebicidal properties. Science, 113, 202-203 (1951)   DOI   PUBMED
6 Mitsunobu, O., The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis, 1, 1-28 (1981)   DOI
7 Taber, D. F., Christos, T. E., Rheingold, A. L., and Guzei, I. A., Synthesis of (-)-Fumagillin. J. Am. Chem. Soc., 121, 5589- 5590 (1999)   DOI   ScienceOn
8 Tarbell, D. S., Carman R. M., Chapman, D. D., Cremer, S. E., Cross, A. D., Huffman, K. R., Kunstmann, M., McCorkindale, N. J., McNally, J. G. Jr., Rosowsky, A., Varino, F. H. L., and West, R. L. The chemistry of fumagillin. J. Am. Chem. Soc., 83, 3096-3113 (1961)   DOI
9 Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Charng, Y, -H., Wu, Z., Biemann, K., and Liu, J. O., Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol., 4(6), 461-471 (1997)   DOI   ScienceOn
10 Hanson, T. E. and Eble F. R., An antiphage agent isolated from Aspergillus sp. J. Bact., 58, 527-529 (1949)
11 Burke, S. D., Fobare, W. F., and Pacofsky, G. J., Chelation control of enolate geometry. Acyclic diastereoselection via the enolate Claisen rearrangement. J. Org. Chem., 48(26), 5221-5228 (1983)   DOI
12 Kallmerten, J. and Gould, T. J., Enolate Claisen rearrangement of glycolate esters. Tetrahedron Lett., 24, 5177-5180 (1983)   DOI   ScienceOn
13 Ingber, D. E., Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy. Seminars in cancer biology., 3, 57-63 (1992)
14 Bedel, O., Haudrechy, A., and LangloisY., A stereoselective formal synthesis of (-)-fumagillol. Eur. J. Org. Chem., 3813- 2819 (2004)   DOI   ScienceOn
15 Corey, E. J. and Snider, B. B. Total synthesis of (${\pm}$)-fumagillin. J. Am. Chem. Soc., 94(7), 2549-2550 (1972)   DOI   PUBMED
16 Roush, W. R., Ando, K., Powers, D. B., Halterman, R. I., and Palkowitz, A. D., Enantioselective synthesis using diisopropyl tartrate-modified (E)- and (Z)-crotylboronates: reactions with achiral aldehydes. Tetrahedron Lett., 29, 5579-5582 (1988)   DOI   ScienceOn
17 Sin, N., Meng, L., Wang, M. Q. W., Wen, J. J., Bornmann, W.G., and Crews, C. M., The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. USA, 94, 6099-6103 (1997)   DOI
18 Gurjar, M. K., Patil, V. J., and Pawar, S. M. Synthesis of (1R,5R)-2,6-dioxabicyclo [3.3.0]octan-3-one from D-glucose. Carbohyd. Res., 165(2), 313-317 (1987)   DOI   ScienceOn
19 Katznelson, H. and Jamieson, C. A., Control of nosema disease of honeybees with fumagillin. Science, 115, 70-71 (1952)   DOI   PUBMED
20 Sato, T., Tajima, K., and Fujisawa, T., Diastereoselective synthesis of erythro- and threo-2-hydroxy-3-methyl-4- pentenoic acids by the ester enolate Claisen rearrangement of 2-butenyl 2-hydroxyacetate. Tetrahedron Lett., 24(7), 729- 730 (1983)   DOI   ScienceOn
21 Fardis, M., Pyun, H. J., Tario, J., Jin, H., Kim, C. U., Ruckman, J., Lin, Y., Greean, L, and Hicke, B., Design, synthesis and evaluation of a series of novel fumagillin analogues. Bioorg. Med. Chem., 11, 5051-5058 (2003)   DOI   ScienceOn
22 Eustache, J. and van de Weghe, The ring-Closing metathesis approach to fumagillol, Strategies and Tactics in Organic Synthesis, Elsevier, Londen, 4, 247-267 (2004)
23 Vosburg, D. A., Weiler, S., and Sorensen, E. J., A concise synthesis of fumagillol. Angew. Chem. Int. Ed., 38, 971-974 (1999)   DOI
24 Vosburg, D. A., Weiler, S., and Sorensen, E. J., Concise stereocontrolled routes to fumagillol, fumagillin, and TNP- 470. Chirality, 15, 156-166 (2003)   DOI   ScienceOn
25 Folkman, J. and Ingber, D., Inhibition of angiogenesis. Seminars in cancer biology. 3, 89-96 (1992)
26 Zhang, P., Nicholson, D. E., Bujnicke, J. M., Su, X., Brendle, J. J., Ferdig, M., Kyle, D. E., Milhous, W. K., and Chiang, P. K., Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. J. Biomed. Sci., 9, 34-40 (2002)   DOI   ScienceOn
27 Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J., Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 345, 555-557 (1990)   DOI   ScienceOn
28 Kim, D., Min, J., Ahn, S. K., Lee, H. W., Choi, N. S., and Moon, S. K., 5-Demethoxyfumagillol, a potent angiogenesis inhibitor isolated from Aspergillus Fumagatus. Chem. Pharm. Bull., 52, 447-450 (2003)   DOI   ScienceOn
29 Boiteau, J. G., Van de Weghe, P., and Eustache, J., A new, ring closing metathesis-based synthesis of (-)-fumagillol. Org. Lett., 3, 2737-2740 (2001)   DOI   ScienceOn
30 Haga, M., Takano, M., and Tejima, S., 3-O-Methyl-D-allose and a facile route to 2- and 3-O-methyl-D-riboses. Carbohyd. Res., 21(3), 440-446 (1972)   DOI   ScienceOn
31 Roush, W. R., Waltz, A. E., and Hong, L. K., Diastereo- and enantioselective aldehyde addition reactions of 2-allyl-1,3,2- dioxaborolane-4,5-dicarboxylic esters, a useful class of tartrate ester modified allylboronates. J. Am. Chem. Soc., 107, 8186 -8190 (1985)   DOI
32 Tarbell, D. S., Carman, R. M., Chapman, D. D., Huffman, K. R., and McCorkindale, N. J., Structure of fumagillin. J. Am. Chem. Soc., 82, 1005-1007 (1960)   DOI
33 Han, C. K., Ahn, S. K., Choi, N. S., Hong, R. K., Moon, S. K., Chun, H. S., Lee, S. J., Kim, J. W., Hong, C. I., Kim, D., Yoon, J. H., and No, K. T., Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2. Bioorg. Med. Chem. Lett., 10(1), 39-43 (2000)   DOI   ScienceOn
34 Steglich, W. and Neises, B., 4-Dialkylaminopyridines as acylation catalysts. 5. Simple method for the esterification of carboxylic acids. Angew. Chem., 90, 556-557 (1978)   DOI